Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FDJN0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,926
Award facts
- Contract value 100% obligated
- $24,926.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at approximately $24,926 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200-unit vials. This delivery order, issued on January 20, 2026, is structured as a firm fixed-price contract with an ultimate completion date of February 10, 2026. The award carries no set-aside designation, indicating that DMS Pharmaceutical Group competed on an unrestricted basis against other qualified vendors. The company will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy established to supply the Department of Defense's global pharmaceutical and medical supply requirements. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor capable of fulfilling diverse pharmaceutical needs for military healthcare facilities worldwide. The company's demonstrated performance across numerous prior delivery orders and its established capability in supplying specialty pharmaceuticals and biologics underscore its critical role as a pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FDJN0?
SPE2DR26FDJN0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FDJN0 worth?
The government has obligated $24,926 on SPE2DR26FDJN0.
Is contract SPE2DR26FDJN0 an order under another contract?
Yes. SPE2DR26FDJN0 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJN0 competed?
The extent of competition for SPE2DR26FDJN0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award